Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging

Archives of General Psychiatry

Volumn 67, Issue 8, 2010, Pages 783-792

  Lui, Su ^a   Li, Tao ^a,f   Deng, Wei ^a   Jiang, Lijun ^a   Wu, Qizhu ^a   Tang, Hehan ^a   Yue, Qiang ^a   Huang, Xiaoqi ^a   Chan, Raymond C ^b   Collier, David A ^f   Meda, Shashwath A ^d   Pearlson, Godfrey ^d,e   Mechelli, Andrea ^f   Sweeney, John A ^c   Gong, Qiyong ^a  

^a SICHUAN UNIVERSITY   (China)

^b INSTITUTE OF PSYCHOLOGY   (China)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d INSTITUTE OF LIVING   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; NEUROLEPTIC AGENT; OXYGEN;

ADULT; AGGRESSION; AMPLITUDE OF LOW FREQUENCY FLUCTUATION; ARTICLE; ATTENUATION; BRAIN FUNCTION; CASE CONTROL STUDY; CAUDATE NUCLEUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENTATE GYRUS; DEPRESSION; DRUG DOSE INCREASE; ECHO PLANAR IMAGING; FEMALE; FREQUENCY ANALYSIS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMPULSIVENESS; INDEPENDENT COMPONENT ANALYSIS; LOW FREQUENCY NOISE; MALE; MENTAL HEALTH CENTER; OXYGEN BLOOD LEVEL; PARANOIA; PARIETAL LOBE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREFRONTAL CORTEX; SCHIZOPHRENIA; SHORT COURSE THERAPY; TEMPORAL CORTEX; THOUGHT DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; BLOOD; BRAIN; BRAIN MAPPING; DRUG EFFECT; HEMISPHERIC DOMINANCE; NERVE CELL NETWORK; NERVE TRACT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; REST; STATISTICS;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; ECHO-PLANAR IMAGING; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; NEURAL PATHWAYS; OXYGEN; PARIETAL LOBE; REST; RISPERIDONE; SCHIZOPHRENIA;

EID: 77955864452     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.84     Document Type: Article

References (66)

1. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry. 1999;46(7):908-920. (Pubitemid 29452982)
2. Fu CH, McGuire PK. Functional neuroimaging in psychiatry. Philos Trans R Soc Lond B Biol Sci. 1999;354(1387):1359-1370.
3. Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry. 2003;160(12):2209-2215. (Pubitemid 39619615)
4. Lui S, Deng W, Huang X, Jiang L, Ma X, Chen H, Zhang T, Li X, Li D, Zou L, Tang H, Zhou XJ, Mechelli A, Collier DA, Sweeney JA, Li T, Gong Q. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry. 2009;166(2):196-205.
5. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007;8(9):700-711. (Pubitemid 47283145)
6. De Luca M, Beckmann CF, De Stefano N, Matthews PM, Smith SM. fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage. 2006;29(4):1359-1367. (Pubitemid 43184199)
7. Logothetis NK, Wandell BA. Interpreting the BOLD signal. Annu Rev Physiol. 2004;66:735-769.
8. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A. 2001;98(2):676-682.
9. Mason MF, Norton MI, Van Horn JD, Wegner DM, Grafton ST, Macrae CN. Wandering minds: the default network and stimulus-independent thought. Science. 2007;315(5810):393-395.
10. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A. 2004;101(13):4637-4642. (Pubitemid 38437463)
11. Garrity AG, Pearlson GD, McKiernan K, Lloyd D, Kiehl KA, Calhoun VD. Aberrant "default mode" functional connectivity in schizophrenia. Am J Psychiatry. 2007;164(3):450-457. (Pubitemid 46513159)
12. Lui S, Huang X, Chen L, Tang H, Zhang T, Li X, Li D, Kuang W, Chan RC, Mechelli A, Sweeney JA, Gong Q. High-field MRI reveals an acute impact on brain function in survivors of the magnitude 8.0 earthquake in China. Proc Natl Acad Sci U S A. 2009;106(36):15412-15417.
13. Shmuel A, Leopold DA. Neuronal correlates of spontaneous fluctuations in fMRI signals in monkey visual cortex: implications for functional connectivity at rest. Hum Brain Mapp. 2008;29(7):751-761. (Pubitemid 351813076)
14. Laufs H, Krakow K, Sterzer P, Eger E, Beyerle A, Salek-Haddadi A, Kleinschmidt A. Electroencephalographic signatures of attentional and cognitive default modes in spontaneous brain activity fluctuations at rest. Proc Natl Acad Sci U S A. 2003;100(19):11053-11058. (Pubitemid 37140151)
15. Gonçalves SI, de Munck JC, Pouwels PJ, Schoonhoven R, Kuijer JP, Maurits NM, Hoogduin JM, Van Someren EJ, Heethaar RM, Lopes da Silva FH. Correlating the alpha rhythm to BOLD using simultaneous EEG/fMRI: intersubject variability. Neuroimage. 2006;30(1):203-213. (Pubitemid 43243210)
16. Tregellas J. Connecting brain structure and function in schizophrenia. Am J Psychiatry. 2009;166(2):134-136.
17. Calhoun VD, Kiehl KA, Pearlson GD. Modulation of temporally coherent brain networks estimated using ICA at rest and during cognitive tasks. Hum Brain Mapp. 2008;29(7):828-838.
18. Zhou Y, Liang M, Jiang T, Tian L, Liu Y, Liu Z, Liu H, Kuang F. Functional dysconnectivity of the dorsolateral prefrontal cortex in first-episode schizophrenia using resting-state fMRI. Neurosci Lett. 2007;417(3):297-302. (Pubitemid 46589786)
19. Liang M, Zhou Y, Jiang T, Liu Z, Tian L, Liu H, Hao Y. Widespread functional disconnectivity in schizophrenia with resting-state functional magnetic resonance imaging. Neuroreport. 2006;17(2):209-213. (Pubitemid 43100329)
20. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. (Pubitemid 18039085)
21. Shehzad Z, Kelly AM, Reiss PT, Gee DG, Gotimer K, Uddin LQ, Lee SH, Margulies DS, Roy AK, Biswal BB, Petkova E, Castellanos FX, Milham MP. The resting brain: unconstrained yet reliable. Cereb Cortex. 2009;19(10):2209-2229.
22. Harrison BJ, Pujol J, Lopez-Sola M, Hernández-Ribas R, Deus J, Ortiz H, Soriano-Mas C, Yücel M, Pantelis C, Cardoner N. Consistency and functional specialization in the default mode brain network. Proc Natl Acad Sci U S A. 2008;105(28):9781-9786. (Pubitemid 352031377)
23. Yang H, Long XY, Yang YH, Yan H, Zhu CZ, Zhou XP, Zang YF, Gong QY. Amplitude of low frequency fluctuation within visual areas revealed by resting-state functional MRI. Neuroimage. 2007;36(1):144-152. (Pubitemid 46617943)
24. Cordes D, Haughton VM, Arfanakis K, Carew JD, Turski PA, Moritz CH, Quigley MA, Meyerand ME. Frequencies contributing tofunctional connectivity in the cerebral cortex in "resting-state" data. AJNR Am J Neuroradiol. 2001;22(7):1326-1333.
25. Dagli MS, Ingeholm JE, Haxby JV. Localization of cardiac-induced signal change in fMRI. Neuroimage. 1999;9(4):407-415.
26. Windischberger C, Langenberger H, Sycha T, Tschernko EM, Fuchsjäger-Mayerl G, Schmetterer L, Moser E. On the origin of respiratory artifacts in BOLD-EPI of the human brain. Magn Reson Imaging. 2002;20(8):575-582. (Pubitemid 35429908)
27. Jafri MJ, Pearlson GD, Stevens M, Calhoun VD. A method for functional network connectivity among spatially independent resting-state components in schizophrenia. Neuroimage. 2008;39(4):1666-1681.
28. Bell AJ, Sejnowski TJ. An information-maximization approach to blind separation and blind deconvolution. Neural Comput. 1995;7(6):1129-1159.
29. Stevens MC, Kiehl KA, Pearlson G, Calhoun VD. Functional neural circuits for mental timekeeping. Hum Brain Mapp. 2007;28(5):394-408. (Pubitemid 46717364)
30. Calhoun VD, Kiehl KA, Liddle PF, Pearlson GD. Aberrant localization of synchronous hemodynamic activity in auditory cortex reliably characterizes schizophrenia. Biol Psychiatry. 2004;55(8):842-849.
31. Calhoun V, Adali T, Kraut M, Pearlson G. A weighted least-squares algorithm for estimation and visualization of relative latencies in event-related functional MRI. Magn Reson Med. 2000;44(6):947-954.
32. Hugdahl K, Loberg EM, Nygard M. Left temporal lobe structural and functional abnormality underlying auditory hallucinations in schizophrenia. Front Neurosci. 2009;3(1):34-45.
33. Corson PW, O'Leary DS, Miller DD, Andreasen NC. The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naive and medicated states. Biol Psychiatry. 2002;52(9):855-862.
34. Berman I, Merson A, Sison C, Allan E, Schaefer C, Loberboym M, Losonczy MF. Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study. Psychopharmacol Bull. 1996;32(1):95-100. (Pubitemid 26176208)
35. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry. 2003;53(7):601-608.
36. Ngan ET, Lane CJ, Ruth TJ, Liddle PF. Immediate and delayed effects of risperidone oncerebral metabolism inneuroleptic naive schizophrenic patients: correlations with symptom change. J Neurol Neurosurg Psychiatry. 2002;72(1):106-110.
37. Molina V, Gispert JD, Reig S, Sanz J, Pascau J, Santos A, Palomo T, Desco M. Cerebral metabolism and risperidone treatment in schizophrenia. Schizophr Res. 2003;60(1):1-7. (Pubitemid 36015782)
38. Molina V, Gispert JD, Reig S, Pascau J, Martínez R, Sanz J, Palomo T, Desco M. Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia. Int Clin Psychopharmacol. 2005;20(1):13-18. (Pubitemid 40105543)
39. Gur RE, Keshavan MS, Lawrie SM. Deconstructing psychosis with human brain imaging. Schizophr Bull. 2007;33(4):921-931. (Pubitemid 47216648)
40. Liddle PF. Cognitive impairment in schizophrenia: its impact on social functioning. Acta Psychiatr Scand Suppl. 2000;400:11-16.
41. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry. 2005;162(12):2233-2245. (Pubitemid 41740200)
42. Hugdahl K, Rund BR, Lund A, Asbjørnsen A, Egeland J, Ersland L, Landrø NI, Roness A, Stordal KI, Sundet K, Thomsen T. Brain activation measured with fMRI during a mental arithmetic task in schizophrenia and major depression. Am J Psychiatry. 2004;161(2):286-293. (Pubitemid 38419280)
43. Braus DF, Weber-Fahr W, Tost H, Ruf M, Henn FA. Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2002;59(8):696-701. (Pubitemid 34847942)
44. Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology. 2008;33(13):3111-3125.
45. Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev. 2008;60(3):358-403.
46. van der Heijden FM, Tuinier S, Fekkes D, Sijben AE, Kahn RS, Verhoeven WM. Atypical antipsychotics and the relevance of glutamate and serotonin. Eur Neuropsychopharmacol. 2004;14(3):259-265. (Pubitemid 38410961)
47. Keefe RS, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull. 1999;25(2):201-222.
48. Lewis DA, Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol. 2006;63(10):1372-1376. (Pubitemid 44547546)
49. Lewis DA, Cho RY, Carter CS, Eklund K, Forster S, Kelly MA, Montrose D. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psychiatry. 2008;165(12):1585-1593.
50. AndreasenNC,Rezai K, Alliger R,SwayzeVWII,FlaumM,Kirchner P,CohenG, O'Leary DS. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry. 1992;49(12):943-958.
51. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry. 2009;66(8):811-822.
52. Gur RE, Resnick SM, Alavi A, Gur RC, Caroff S, Dann R, Silver FL, Saykin AJ, Chawluk JB, Kushner M, et al. Regional brain function in schizophrenia, I: a positron emission tomography study. Arch Gen Psychiatry. 1987;44(2):119-125. (Pubitemid 17006450)
53. Quak J, Paans AMJ, van den Bosch RJ, Korf J. Prefrontal involvement in schizophrenia. Schizophr Res. 1998;29(1):107-108.
54. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S. Glucosemetabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry. 1990;156:216-227. (Pubitemid 20071995)
55. Karry R, Klein E, Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry. 2004;55(7):676-684. (Pubitemid 38376178)
56. Blass JP. Glucose/mitochondria in neurological conditions. Int Rev Neurobiol. 2002;51:325-376.
57. Honey CJ, Kotter R, Breakspear M, Sporns O. Network structure of cerebral cortex shapes functional connectivity on multiple time scales. Proc Natl Acad Sci U S A. 2007;104(24):10240-10245. (Pubitemid 47175293)
58. Anand A, Li Y, Wang Y, Wu J, Gao S, Bukhari L, Mathews VP, Kalnin A, Lowe MJ. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biol Psychiatry. 2005;57(10):1079-1088. (Pubitemid 40615768)
59. Li SJ, Biswal B, Li Z, Risinger R, Rainey C, Cho JK, Salmeron BJ, Stein EA. Cocaine administration decreases functional connectivity in human primary visual and motor cortex as detected by functional MRI. Magn Reson Med. 2000;43(1):45-51. (Pubitemid 30027111)
60. Anderson CM, Lowen SB, Renshaw PF. Emotional task-dependent low-frequency fluctuations and methylphenidate: wavelet scaling analysis of 1/f-type fluctuations in fMRI of the cerebellar vermis. J Neurosci Methods. 2006;151(1):52-61.
61. Bluhm RL, Miller J, Lanius RA, Osuch EA, Boksman K, Neufeld RW, Théberge J, Schaefer B, Williamson P. Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network. Schizophr Bull. 2007;33(4):1004-1012. (Pubitemid 47216653)
62. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry. 1996;153(1):41-49.
63. Harris MS, Wiseman CL, Reilly JL, Keshavan MS, Sweeney JA. Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia. Neuropsychopharmacology. 2009;34(2):468-476.
64. Lencer R, Sprenger A, Harris MS, Reilly JL, Keshavan MS, Sweeney JA. Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia. Arch Gen Psychiatry. 2008;65(10):1146-1154.
65. Reilly JL, Harris MS, Khine TT, Keshavan MS, Sweeney JA. Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia. Biol Psychiatry. 2007;62(7):818-821.
66. Birn RM, Diamond JB, Smith MA, Bandettini PA. Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI. Neuroimage. 2006;31(4):1536-1548.